Search

everythinglearnresearchcommunity

for

Search:↓

Using the drugs AMD3100 and Tacrolimus together greatly improves skin healing and hair growth after a deep skin cut by increasing stem cells in the wound.

Gab1 protein is crucial for hair growth and stem cell renewal, and Mapk signaling helps maintain these processes.

Hair graying is caused by damage and cell depletion but might be temporarily reversible with drugs and hormones.

Dermal sheath cells help heal wounds by showing both skin and connective tissue traits.

Early detection and multidisciplinary management of skin and mouth side effects from breast cancer treatments improve patient outcomes.

NFATc1 controls hair stem cell activity, affecting hair growth and could be a target for hair loss treatments.

Stem cells in the eye have different roles and behaviors, helping maintain and repair the eye's surface.

The study created a mouse model to better understand hair follicle stem cells' role in hair growth and repair.

Innate lymphoid cells help control skin bacteria by regulating sebaceous glands.

Vitamin D receptor is crucial for normal hair growth and preventing hair loss.

Dermal fibroblasts have adjustable roles in wound healing, with specific cells promoting regeneration or scar formation.

Fibroblast state switching is crucial for skin healing and development.

Zebrafish skin regeneration relies on cell behaviors and reactive oxygen species, with antioxidants reducing and hydrogen peroxide increasing regeneration.

Dexamethasone may influence hair growth by altering estrogen receptor activity in hair cells.

CD80 on skin stem cells helps expand Treg cells to aid wound healing.

Boosting β-catenin signaling in certain skin cells can enhance hair growth.

Zebrafish need MYC and FGF to regenerate inner ear hair cells.

Sox9 is crucial for hair follicle stem cells to become melanocytes instead of glial cells.

Epirubicin and cyclophosphamide cause more anemia and side effects than docetaxel and cyclophosphamide, but both are equally effective.

Using three different drugs together may better treat eye diseases like glaucoma and macular degeneration.

Keratinocyte cytokines and genetic variations influence the development of moles and skin pigmentation.

Hormonal therapies can improve skin issues by adjusting hormone levels, with future advancements promising better results.

Premature graying of hair is mainly caused by genetics, stress, and environment, with potential treatments being explored.

Skin side effects from CDK4/6 inhibitors in breast cancer patients are generally mild and treatable, allowing most patients to continue treatment.

Combining hyperthermia with natural compounds and conventional treatments improves cancer therapy effectiveness and reduces side effects.

Gray hair can potentially be managed or reversed with treatments that boost melanin production and address nutritional deficiencies.

PIEZO1 helps keep hair follicle stem cells inactive, affecting hair growth.

Consult an oncologist before using supplements for hair loss during breast cancer treatment.

Gefitinib and Sasam-Kyeongokgo together significantly reduce cancer growth and improve immune response in mice.

A faulty KLHL24 gene leads to hair loss by damaging hair follicle stem cells.